Cargando…
Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis
To fight against coronavirus disease 2019 (COVID-19), the vaccination is currently the most effective approach. However, in addition to common systemic side effects, the vaccines can cause serious allergic reactions or anaphylaxis. In anaphylaxis, the exposure to the allergen causes a sudden release...
Autor principal: | Kazama, Itsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666472/ https://www.ncbi.nlm.nih.gov/pubmed/34903238 http://dx.doi.org/10.1186/s12948-021-00162-9 |
Ejemplares similares
-
Catechin synergistically potentiates mast cell-stabilizing property of caffeine
por: Yashima, Misaki, et al.
Publicado: (2021) -
Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease
por: Kazama, Itsuro
Publicado: (2022) -
Auditing the efficacy of prophylactic measures against Covid-19 amongst Healthcare workers in India
por: Pillai, Ashwin, et al.
Publicado: (2021) -
PD-1 Regulates Passive Anaphylaxis: A Possible Role of the Mast Cell Intracellular Inhibitory Signal
por: Ogawa, Tatsuya, et al.
Publicado: (2021) -
Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
por: Somiya, Masaharu, et al.
Publicado: (2021)